Oncology Highlights - September 2018
Nobel prize in medicine goes for cancer immunotherapy, linking sugar to cancer, Roche acquires Tusk, FDA guidelines on adaptive trials and more
Combination immunotherapy: The latest revolution in cancer treatment
An analysis of the clinical landscape The present focus in the treatment of cancer is immunotherapy, in particular immunotherapies that are trialed in a combination regimen. By combining immuno-oncology (IO) agents with oth...